Reclast, also known as zoledronic acid, is a medication commonly used to treat osteoporosis and certain other bone conditions. For Medicare beneficiaries seeking this treatment, it’s essential to understand whether Medicare covers Reclast infusions and what costs may be involved.
Your Medicare plan my help cover the cost of Reclast, depending on several factors. In this article, we will explore Medicare coverage for Reclast infusion, eligibility criteria, and the average cost associated with this treatment.
Learn More About Coverage With Our Free Medicare Course
Medicare Coverage for Reclast Infusion
Medicare is a federal health insurance program that provides coverage for eligible individuals aged 65 and older, as well as some younger individuals with disabilities. When it comes to coverage for medications like Reclast, Medicare offers several different parts and plans, each with its own rules and guidelines.
- Medicare Part B: Reclast infusion typically falls under the coverage provided by Medicare Part B. Part B covers certain outpatient prescription drugs when they are considered medically necessary. This includes drugs that are administered by a healthcare provider in an outpatient setting, such as a doctor’s office or clinic. For Medicare to cover Reclast under Part B, your healthcare provider must deem it medically necessary.
- Medicare Advantage Plans: Some Medicare beneficiaries choose to enroll in Medicare Advantage plans (Part C) offered by private insurance companies. These plans often include prescription drug coverage, and the specific coverage for Reclast may vary depending on the plan. It’s essential to check with your Medicare Advantage plan provider to determine whether Reclast is covered and what the associated costs might be.
- Medicare Part D: Medicare Part D is the prescription drug coverage portion of Medicare. While Part D primarily covers prescription medications you take on your own (typically in pill form), it may also cover medications that are self-administered under certain circumstances. However, Reclast infusion is not typically covered under Part D, as it is administered by a healthcare professional.
Eligibility and Criteria
To have Reclast infusion covered by Medicare, there are some criteria that must be met:
- Medical Necessity: Your healthcare provider must determine that Reclast infusion is medically necessary for the treatment of a qualified condition, such as osteoporosis.
- Inpatient vs. Outpatient: Reclast infusion should be administered in an outpatient setting, such as a doctor’s office or clinic, for Medicare to consider coverage.
- Medicare Part B Enrollment: In most cases, you must be enrolled in Medicare Part B to have Reclast infusion covered under this program.
The Average Cost of Reclast Infusion
The cost of Reclast infusion can vary depending on several factors, including your location, the healthcare facility, and whether you have supplemental insurance coverage. To give you a general idea, the average cost for a single Reclast infusion session could range from $200 to $1,000+ without insurance.
If you have Medicare Part B, the program typically covers a significant portion of the cost. You will be responsible for the Part B deductible, which can change each year, and a 20% coinsurance for the Medicare-approved amount. However, if you have a Medicare Supplement Insurance (Medigap) policy, it may help cover the out-of-pocket costs associated with Part B coverage.
Contact The Mair Agency Today
If you’re not sure whether your Medicare plan covers Reclast, contact The Mair Agency today! One of our Medicare experts can walk you through your plan and coverage!
Frequently Asked Questions About Medicare and Reclast Infusion
Does Medicare cover Reclast infusion?
Yes, Medicare Part B typically covers Reclast infusions when they are deemed medically necessary by your healthcare provider. Because Reclast is administered by a healthcare professional in an outpatient setting, such as a doctor’s office or infusion clinic, it falls under Part B’s coverage for outpatient drugs rather than Part D.
How much does a Reclast infusion cost with Medicare?
With Medicare Part B, you are responsible for the annual Part B deductible ($257 in 2025) and 20% coinsurance on the Medicare-approved amount. Without insurance, a single Reclast infusion can range from $200 to over $1,000 depending on where it is administered. If you have a Medicare Supplement (Medigap) plan, it may cover some or all of your 20% share.
How much does Reclast cost without insurance?
The out-of-pocket cost of a Reclast infusion without insurance typically ranges from $200 to $1,000 or more, depending on the healthcare facility and your location. The drug itself (zoledronic acid) has a generic version that can significantly reduce costs compared to brand-name Reclast.
Is Reclast covered by Medicare Part D?
Generally, no. Because Reclast is administered by a healthcare professional rather than self-administered at home, it is not typically covered under Medicare Part D prescription drug plans. Coverage usually falls under Medicare Part B as an outpatient drug.
What conditions qualify for Medicare coverage of Reclast?
Medicare Part B covers Reclast when your doctor determines it is medically necessary for a qualifying condition. The most common qualifying conditions include osteoporosis, Paget’s disease of bone, and certain bone complications related to cancer. Your provider must document the medical necessity in order for the claim to be approved.
Does Medicare Advantage cover Reclast infusion?
Medicare Advantage (Part C) plans are required to cover everything Original Medicare covers, so Reclast infusion should be covered when medically necessary. However, cost-sharing, network requirements, and prior authorization rules vary by plan. Always check with your specific Medicare Advantage plan before scheduling your infusion to avoid unexpected costs.
Learn More About Coverage With Our Free Medicare Course